Reports of colorectal cancer have indicated that patients with a loss of MHS2 or MSH6 related-proteins in IHC screening were more likely to have LS-related colorectal cancer, whereas cases with loss of MLH1 or PSM2related-proteins were more likely to have sporadic colorectal cancer [7]. Here, MSH6 is linked to colorectal cancer.